Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$24.28 - $56.64 $2.67 Million - $6.23 Million
-110,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$24.23 - $28.59 $484,600 - $571,800
-20,000 Reduced 15.38%
110,000 $2.83 Million
Q1 2021

May 14, 2021

SELL
$13.77 - $21.66 $137,700 - $216,600
-10,000 Reduced 7.14%
130,000 $2.78 Million
Q4 2020

Feb 16, 2021

BUY
$10.75 - $14.91 $430,000 - $596,400
40,000 Added 40.0%
140,000 $1.89 Million
Q3 2020

Nov 16, 2020

BUY
$11.98 - $16.34 $1.2 Million - $1.63 Million
100,000 New
100,000 $1.27 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.56B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.